JPMorgan Chase & Co. boosted its stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) by 131.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 228,652 shares of the company's stock after buying an additional 129,854 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.59% of Viemed Healthcare worth $1,834,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Bard Associates Inc. lifted its stake in shares of Viemed Healthcare by 1.3% during the fourth quarter. Bard Associates Inc. now owns 349,526 shares of the company's stock valued at $2,803,000 after buying an additional 4,474 shares during the period. First Eagle Investment Management LLC lifted its stake in shares of Viemed Healthcare by 196.5% during the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company's stock worth $2,637,000 after purchasing an additional 217,923 shares during the period. Rice Hall James & Associates LLC acquired a new stake in shares of Viemed Healthcare during the fourth quarter worth $2,083,000. LPL Financial LLC grew its position in shares of Viemed Healthcare by 1.6% in the fourth quarter. LPL Financial LLC now owns 194,690 shares of the company's stock valued at $1,561,000 after purchasing an additional 3,000 shares during the period. Finally, Barclays PLC increased its stake in Viemed Healthcare by 342.3% in the third quarter. Barclays PLC now owns 53,439 shares of the company's stock valued at $392,000 after purchasing an additional 41,358 shares during the last quarter. Institutional investors and hedge funds own 74.24% of the company's stock.
Viemed Healthcare Stock Performance
NASDAQ VMD remained flat at $7.07 during trading hours on Monday. The company had a trading volume of 119,443 shares, compared to its average volume of 139,214. The stock has a 50-day simple moving average of $7.23 and a 200 day simple moving average of $8.05. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a 1 year low of $6.21 and a 1 year high of $9.81. The firm has a market capitalization of $279.42 million, a price-to-earnings ratio of 26.19 and a beta of 1.64.
About Viemed Healthcare
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Articles
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
